StonvexLoading…
StonvexStonvexStonvexCore line items from FTI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.49B | $9.93B | $7.42B | $4.77B |
Operating Income | $386.10M | $1.44B | $1.12B | $681.80M |
Net Income | $260.50M | $963.90M | $721.20M | $411.50M |
EPS (Diluted) | $0.64 | $2.30 | $1.71 | $0.97 |
Total Assets | $10.09B | $10.12B | $10.25B | $10.08B |
Total Liabilities | $6.72B | $6.71B | $6.88B | $6.79B |
Cash & Equivalents | $960.80M | $1.03B | $876.60M | $950.00M |
Free Cash Flow OCF − CapEx | $276.90M | $1.45B | $1.09B | $640.50M |
Shares Outstanding | 398.70M | 400.70M | 404.50M | 411.00M |